MyFinsight
Home
Blog
About
Back
Balance Sheet
Kairos Pharma, LTD. (KAPA)
Kairos Pharma, LTD. (KAPA)
source: myfinsight.com
Vendor advances, gross
$1,756K
(-46.32%↓ Y/Y)
Cash and cash
equivalents
$2,626K
(-13.45%↓ Y/Y)
Vendor advances, net
$412K
(-76.00%↓ Y/Y)
Prepaid expenses and
other current assets
$136K
(54.55%↑ Y/Y)
Deferred offering costs
$1,282K
(-24.23%↓ Y/Y)
Less accumulated
amortization
$1,344K
(-13.51%↓ Y/Y)
Total current assets
$3,174K
(-34.41%↓ Y/Y)
Total other assets
$1,282K
(-30.10%↓ Y/Y)
Total assets
$4,456K
(-33.22%↓ Y/Y)
Total liabilities and
shareholders equity
$4,456K
(-33.22%↓ Y/Y)
Total shareholders
equity
$4,191K
(-30.12%↓ Y/Y)
Total current
liabilities
$265K
(-60.80%↓ Y/Y)
Accumulated deficit
-$17,304K
(-50.48%↓ Y/Y)
Additional paid-in capital
$21,474K
(22.86%↑ Y/Y)
Accounts payable and
accrued expenses
$265K
(-60.80%↓ Y/Y)
Common stock, par value
0.001, 100,000,000...
$21K
(16.67%↑ Y/Y)
Back